Growth Metrics

Mainz Biomed N.V (MYNZ) EPS (Basic): 2019-2024

Historic EPS (Basic) for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$22.36.

  • Mainz Biomed N.V's EPS (Basic) rose 45.26% to -$12.38 in Q4 2023 from the same period last year, while for Dec 2023 it was -$67.81, marking a year-over-year increase of 15.80%. This contributed to the annual value of -$22.36 for FY2024, which is 65.47% up from last year.
  • Latest data reveals that Mainz Biomed N.V reported EPS (Basic) of -$22.36 as of FY2024, which was up 65.47% from -$64.76 recorded in FY2023.
  • Mainz Biomed N.V's EPS (Basic)'s 5-year high stood at -$0.10 during FY2020, with a 5-year trough of -$74.55 in FY2022.
  • For the 3-year period, Mainz Biomed N.V's EPS (Basic) averaged around -$53.89, with its median value being -$64.76 (2023).
  • Per our database at Business Quant, Mainz Biomed N.V's EPS (Basic) crashed by 4,501.85% in 2022 and then skyrocketed by 65.47% in 2024.
  • Over the past 5 years, Mainz Biomed N.V's EPS (Basic) (Yearly) stood at -$0.10 in 2020, then plummeted by 1,520.00% to -$1.62 in 2021, then crashed by 4,501.85% to -$74.55 in 2022, then climbed by 13.13% to -$64.76 in 2023, then soared by 65.47% to -$22.36 in 2024.